Johnson & Johnson (JNJ) Revenue (2009 - 2026)

Johnson & Johnson has disclosed Revenue across 18 years of filings, most recently posting $24.1 billion for Q1 2026.

• Revenue for Q1 2026 came in at $24.1 billion, up 9.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $96.4 billion (up 7.87% YoY), and the FY2025 annual result was $94.2 billion, up 6.05% from the prior year.
• Revenue came in at $24.1 billion for Q1 2026 at Johnson & Johnson, down from $24.6 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $24.6 billion in Q4 2025 to a low of $19.8 billion in Q2 2022.
• The 5-year median for Revenue is $21.5 billion (2023), against an average of $21.9 billion.
• Across the five-year window, Revenue slipped 14.32% in 2022 and gained 9.91% in 2026, its largest moves.
• Johnson & Johnson's Revenue stood at $20.0 billion in 2022, then gained by 7.0% to $21.4 billion in 2023, then grew by 5.26% to $22.5 billion in 2024, then grew by 9.08% to $24.6 billion in 2025, then decreased by 2.04% to $24.1 billion in 2026.
• The last three Revenue figures came in at $24.1 billion (Q1 2026), $24.6 billion (Q4 2025), and $24.0 billion (Q3 2025), per Business Quant data.